• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » AAA IDE study expands, hopes to add Aortica software

AAA IDE study expands, hopes to add Aortica software

September 18, 2015 By Fink Densford

Aortica

Aortica said today that a physician-sponsored investigational device exemption study of abdominal aortic aneurysm-treating endografts gained FDA approval to introduce a new software-planning tool and expand the number of endografts in the study.

The trial is designed to assess new technology that could reduce the need for invasive surgeries in patients with aneurysms that are “too close to (or encompass) branch arteries that supply blood to vital organs,” the Bellevue, Wash.-based company said.

“In our study, we are introducing an algorithm that I call Patient Match Technology, which will dramatically simplify the FEVAR procedure. The algorithm digitizes a patient’s CT scan and uses a 3D printer to create an exact replica of each patient’s aortic anatomy. From this template, we can customize an ‘off-the-shelf’ endograft to precisely match each patient’s anatomy. This algorithm is currently being refined and automated by an early stage privately held company founded by Starnes called Aortica Corp,” lead investigator Dr. Benjamin Starnes of the Harborview Medical Center said in a press release.

Aortica, and Dr. Starnes, hope to incorporate Aoritca’s Reflection System technology into the trial later this year or in early 2016, according to a press release.

“With FDA’s approval of this supplement to the IDE, we can begin to demonstrate the broad applicability of the Patient Match Technology across the vast majority of endografts available on the market today. Down the road, we hope the addition of the Aortica’s automated version—called the Reflection System—will yield both a technology and an approach that will eliminate the hours of planning, heavy expense, and the general ‘headache’ currently experienced by physicians and institutions interested in treating these patients less invasively,” Starnes said in prepared remarks.

Aortica is developing a “patient-specific” solution that combines patient CT scans with proprietary software and 3-D printing to personalize endografts to fit each patients unique anatomy, according to the company.

Filed Under: Clinical Trials, Food & Drug Administration (FDA) Tagged With: Aortica

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy